HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $54 | – | 180 | +3500.0% | 0.00% | – |
| Q3 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q4 2021 | $35,000 | -28.6% | 31,149 | -2.7% | 0.00% | – |
| Q3 2021 | $49,000 | +2350.0% | 32,004 | +3935.8% | 0.00% | – |
| Q2 2021 | $2,000 | -99.1% | 793 | -99.4% | 0.00% | – |
| Q1 2021 | $228,000 | – | 123,654 | +2472980.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q3 2020 | $103,000 | – | 33,215 | +664200.0% | 0.00% | – |
| Q2 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 5 | -54.5% | 0.00% | – |
| Q3 2019 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |